Why AcelRx Pharmaceuticals Inc Stock Boomed

Following a confirmation of its PDUFA date, AcelRx reeled in gains as regulatory approval looks likely

Jul 25, 2014 at 2:50PM

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of AcelRx Pharmaceuticals (NASDAQ:ACRX), a health care company developing the Zalviso pain-managing drug delivery system, jumped by as much as 11% today after the company confirmed its July 27 PDUFA date for Zalviso with the FDA.

So what: According to the company's press release, rumors had swirled that regulators already had approved the device -- but so far, AcelRx noted that it hasn't heard an answer over its regulatory filing for Zalviso. Investors, however, have rallied around the stock as analysts grow optimistic over an FDA approval for Zalviso. Piper Jaffrey noted last month that it expects a "timely approval" of the device around its PDUFA date, particularly after Zalviso posted strong safety and efficacy data in earlier clinical trials.

Now what: Signs are looking good for Zalviso's approval moving forward, and today's stock jump points to investor confidence in just that outcome. There's a sizable opportunity here for AcelRx: The company's drug delivery and pain-management system is aiming to compete with traditional IV-delivered pain control in hospitals, a practice AcelRx notes can lead to infections, human errors, and other potential hazards.

Zalviso has already won its share of supporters. AcelRx inked a deal worth up to $250 million to sell the system's European and Australian rights to German company Grunenthal GmbH, and Piper Jaffray foresees up to $300 million to $400 million in peak U.S. sales for the system if approved.

Risk-free for 30 days: The Motley Fool's flagship service
Tom and David Gardner founded The Motley Fool over 20 years ago with the goal of helping the world invest... better. Their flagship service, Stock Advisor, has helped thousands of investors take control of their financial lives and beat the market. Click here to sign up today.

Dan Carroll has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information